Latest filing published 14 Oct 2022 for Forma Therapeutics Holdings, Inc..
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Todd Shegog is a declared insider of Forma Therapeutics Holdings, Inc. (senior executive), with filings sourced from SEC (Form 4). We count 5 filings; the first trade dates from 26 February 2021 and the latest from 14 October 2022.
On the market, this insider has only sold: 1 sale, €49k in total. Outside the open market, there are 3 share grants. 2022 to date brings no purchases and 1 sale.
On 14 October 2022 came the latest disclosure, a transaction in Forma Therapeutics Holdings, Inc. Typically, a trade is published a median of 3 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations